- Home
- EIG vs IMTX Comparison
EIG vs IMTX Comparison
Compare EIG & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIG
- IMTX
- Stock Information
- Founded
- EIG 2000
- IMTX N/A
- Country
- EIG United States
- IMTX Germany
- Employees
- EIG N/A
- IMTX N/A
- Industry
- EIG Property-Casualty Insurers
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EIG Finance
- IMTX Health Care
- Exchange
- EIG Nasdaq
- IMTX Nasdaq
- Market Cap
- EIG 986.1M
- IMTX 865.5M
- IPO Year
- EIG 2007
- IMTX N/A
- Fundamental
- Price
- EIG $40.29
- IMTX $10.34
- Analyst Decision
- EIG Strong Buy
- IMTX Strong Buy
- Analyst Count
- EIG 1
- IMTX 4
- Target Price
- EIG $58.00
- IMTX $13.67
- AVG Volume (30 Days)
- EIG 123.2K
- IMTX 1.0M
- Earning Date
- EIG 10-30-2025
- IMTX 11-17-2025
- Dividend Yield
- EIG 3.18%
- IMTX N/A
- EPS Growth
- EIG N/A
- IMTX N/A
- EPS
- EIG 4.10
- IMTX N/A
- Revenue
- EIG $889,500,000.00
- IMTX $152,823,253.00
- Revenue This Year
- EIG $1.18
- IMTX N/A
- Revenue Next Year
- EIG N/A
- IMTX $13.53
- P/E Ratio
- EIG $9.83
- IMTX N/A
- Revenue Growth
- EIG 2.32
- IMTX 83.61
- 52 Week Low
- EIG $38.19
- IMTX $3.30
- 52 Week High
- EIG $54.44
- IMTX $11.25
- Technical
- Relative Strength Index (RSI)
- EIG 35.91
- IMTX 61.02
- Support Level
- EIG $40.20
- IMTX $9.99
- Resistance Level
- EIG $42.31
- IMTX $10.87
- Average True Range (ATR)
- EIG 0.65
- IMTX 0.59
- MACD
- EIG -0.11
- IMTX -0.14
- Stochastic Oscillator
- EIG 9.36
- IMTX 40.64
About EIG Employers Holdings Inc
Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.